title: Drug approvals in India.
authors.affiliation: Cadila Healthcare, Zydus Research Centre, Ahmedabad 382210, Gujarat, India.
authors.forename: Mukul
authors.initials: M
authors.lastname: Jain
authors.affiliation: Cadila Healthcare, Zydus Research Centre, Ahmedabad 382210, Gujarat, India. Electronic address: rhjani@zyduscadila.com.
authors.forename: Rajendrakumar H
authors.initials: RH
authors.lastname: Jani
mesh_terms: D001599:Berberine / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017277:Drug Approval; D004345:Drug Industry; D050171:Dyslipidemias / Q000188:drug therapy*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D040541:Marketing; D010666:Phenylpropionates / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*
chemical_list: D010666:Phenylpropionates; D011758:Pyrroles; D001599:Berberine; D006886:Hydroxychloroquine